|
Video: What is a Stock Split?
|
|
Genocea Biosciences is a biopharmaceutical company that discovers and develops cancer immunotherapies using its ATLAS platform. The ATLAS platform profiles each patient's CD4+ and CD8+ T cell immune responses to every potential target or antigen identified by sequencing of that patient's tumor. Co.'s GEN-011 program is an adoptive T cell therapy using neoantigen-targeted peripheral cells (NPTs). The GEN-011 NPTs are specific for ATLAS identified anti-tumor antigens that are used to manufacture peripheral blood-derived, tumor-specific T cell therapy. Co.'s GEN-009 program is a neoantigen vaccine delivering adjuvanted synthetic long peptides spanning ATLAS-identified anti-tumor neoantigens. According to our GNCA split history records, GNCA has had 1 split. | |
|
GNCA (GNCA) has 1 split in our GNCA split history database. The split for GNCA took place on May 22, 2019. This was a 1 for 8 reverse split, meaning for each 8 shares of GNCA owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 125 share position following the split.
When a company such as GNCA conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the GNCA split history from start to finish, an original position size of 1000 shares would have turned into 125 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into GNCA shares, starting with a $10,000 purchase of GNCA, presented on a split-history-adjusted basis factoring in the complete GNCA split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/31/2014 |
|
End date: |
06/02/2022 |
|
Start price/share: |
$145.52 |
|
End price/share: |
$0.05 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.96% |
|
Average Annual Total Return: |
-62.20% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$3.51 |
|
Years: |
8.18 |
|
|
|
Date |
Ratio |
05/22/2019 | 1 for 8 |
|
|